BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33457635
Number of visits today
2842
Number of downloads
16640823
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Duyan M, Ozturan IU. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness? SN Compr Clin Med 2021;:1-3. [PMID: 33997622 DOI: 10.1007/s42399-021-00952-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Rittmannsberger H, Barth M, Malik P, Malsiner-Walli G, Yazdi K. First-episode psychotic disorders in the wake of the COVID-19 pandemic: a descriptive review of casereports. Acta Neuropsychiatr 2022;34:289-310. [PMID: 35357298 DOI: 10.1017/neu.2022.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Harismah K, Shahrtash S, Arabi A, Khadivi R, Mirzaei M, Akhavan-sigari R. Favipiravir attachment to a conical nanocarbon: DFT assessments of the drug delivery approach. Computational and Theoretical Chemistry 2022;1216:113866. [DOI: 10.1016/j.comptc.2022.113866] [Reference Citation Analysis]
3 Carmassi C, Pacciardi B, Gravina D, Fantasia S, De Pascale G, Cutuli SL, Bertelloni CA, Dell'Osso L. Pharmacological Treatment of Acute Psychiatric Symptoms in COVID-19 Patients: A Systematic Review and a Case Series. Int J Environ Res Public Health 2022;19:4978. [PMID: 35564372 DOI: 10.3390/ijerph19094978] [Reference Citation Analysis]
4 . Favipiravir. Reactions Weekly 2022;1902:207-207. [DOI: 10.1007/s40278-022-13351-6] [Reference Citation Analysis]
5 Finsterer J, Scorza FA. Mental compromise in SARS-CoV-2 infected patients is multicausal, organic or inorganic. Brain Commun 2021;3:fcab218. [PMID: 34557670 DOI: 10.1093/braincomms/fcab218] [Reference Citation Analysis]
6 Hossain MJ, Jannat T, Brishty SR, Roy U, Mitra S, Rafi MO, Islam MR, Nesa ML, Islam MA, Emran TB. Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far. Biologics 2021;1:252-84. [DOI: 10.3390/biologics1020016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345